Pharmaceutical industry news

Ultragenyx (RARE) Stock Could Stay Fully Priced On Setrusumab Regulatory Talks

Cathay Biotech: Revenue and net profit surged on business expansion and new product lines, with robust R&D investment

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melano

CORDIS project: BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

CORDIS project: European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

CORDIS project: In-silico Development- and Clinical-Trial-Platform for Testing in-situ Tissue Engineered Heart Valves

CORDIS project: Immune Niches for Cancer ImmunoTherapy Enhancement

CORDIS project: Ultra-fast Antimicrobial Susceptibility Test for diagnosing antimicrobial resistance to provide personalized antibiotic treatments

CORDIS project: Optoelectronic medicine - nerve cell regulation with light

Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. Sanctions

CORDIS project: Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

The biotech bi-weekly: NIH maternal health research prizes, a virtual human cell model and chondrocyte spheroids to treat joint degeneration

The New Frontier of Pharmaceutical Growth

GenBio Inc. Highlights Strategic Importance of Emerging Biotechnology Amid Expansion of U.S. Pharmaceutical Investment

Moderna Shares Skyrocket Up to 90% as Its mRNA Cancer Vaccine With Merck Succeeds in Late-Stage Trial

Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $5.00 by Analysts at HC Wainwright

Moderna Surges Over 100% Pre-Market as Phase 3 Cancer Vaccine Trial With Merck Succeeds

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

VRAX Stock Whipsaws As Traders Target Volatile Biotech Play

High Quality Undervalued Stocks Backed By Cash Flow In Japan

Biodexa's trial for a hereditary polyp condition passes halfway at 87 recruits

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

ENCLONY Accelerates Global Expansion with Advanced Pharmaceutical Vision Inspection Technology

Jefferies Adjusts Genscript Biotech's Price Target to HK$30 From HK$15.50, Keeps at Buy

Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results

BMO Capital Markets Initiates Coverage on BioMarin Pharmaceutical (NASDAQ:BMRN)

Medizinischer Fortschritt benötigt klinische Forschung

Moderna, Merck's Personalized mRNA Cancer Vaccine Achieves First Late-Stage Trial Success

StatStrip® Glucose And Beta-Ketone Hospital Meter

A software issue in StatStrip (Gen 2) Glucose and Beta-Ketone Hospital Meters may retain previous pa...

SPECTRALIS® with Flex Module

There is a possibility that the castor wheels of the Flex stand are not properly attached. The wheel...

Embosphere® Microspheres-Syringe

Merit Medical Systems, Inc., on behalf of its subsidiary, Biosphere Medical, is voluntarily recallin...

A bioengineered vessel beat fistulas for women and men with obesity and diabetes on dialysis

Personalized mRNA cancer vaccine succeeds in major phase 3 melanoma trial

Sino Biopharmaceutical Launches Global Brand SBP Group; First-Half Overseas Licensing Deals Surpass $3.4 Billion

Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?

Helus Pharma stock rating reiterated at Buy by H.C. Wainwright

Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?

H.C. Wainwright cuts Oncolytics Biotech price target to $5 on pipeline shift

Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models

10,000-plus in South Korea are estimated to have a rare retinal disease; Kiora licenses KIO-301

Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation

Nonprofit Cville BioHub working to develop local talent for AstraZeneca and the area’s growing biotech industry

Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push

Merck and Moderna report first positive Phase 3 readout for an investigational mRNA therapy

Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccine

Trump expected to nominate Heidi Overton as new FDA commissioner

Meeder Asset Management Inc. Makes New Investment in West Pharmaceutical Services, Inc. $WST

Operation TrialBlazer: How the FDA’s Expedited IND Pilot Program Aims to Halve Early Clinical Timelines

AI integration in pharmaceutical processes remains focused on high-impact functions

Three years into the UPC: The Hague takes the lead in pharmaceutical patent litigation

Study of 3,400 children links London's Ultra Low Emission Zone with improved lung growth

symbol__ Stock Quote Price and Forecast

Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?

Neoimmunetech licenses NT-I7 rights to U.S. biotech in $260 million deal - CHOSUNBIZ

Pune: FDA Suspends Hotel Chul Muttons Licence; Banned Products Worth ₹10 Lakh Seized In 4-Day Drive

BIOG Keeps Its Focus On Small-cap Biotech And M&A Potential

Pharma in hackers' crosshairs as Amgen breach moves to courts

Dash Bio banks $30 million to automate development bottleneck